These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interaction of dantrolene sodium with human serum albumin. Vallner JJ; Sternson LA; Parsons DL J Pharm Sci; 1976 Jun; 65(6):873-7. PubMed ID: 932973 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of dantrolene sodium in children. Lietman PS; Haslam RH; Walcher JR Arch Phys Med Rehabil; 1974 Aug; 55(8):388-92. PubMed ID: 4853611 [No Abstract] [Full Text] [Related]
5. The effect of dantrolene sodium on rat skeletal muscle in relation to the plasma concentration. Meyler WJ; Mols-Thurkow I; Scaf AH; Sargo S; Wesseling H Eur J Pharmacol; 1979 Feb; 53(4):335-42. PubMed ID: 421731 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of 5-hydroxy-1-((5-(p-nitrophenyl)furfurylidene)-amino) hydantoin, a metabolite of dantrolene. White RL; Schwan TJ J Pharm Sci; 1976 Jan; 65(1):. PubMed ID: 1255409 [TBL] [Abstract][Full Text] [Related]
7. [The interactions between dantrolene and bovine serum albumin]. Tanaka S; Wakamatsu M; Shimonaka H; Sone T; Tanahashi T; Uematsu H; Yamamoto M; Kawai K; Nozawa Y Masui; 1987 Jan; 36(1):65-70. PubMed ID: 3560428 [No Abstract] [Full Text] [Related]
8. Qualitative method for dantrolene and a related metabolite in urine. Conklin JD; Sobers RJ J Pharm Sci; 1973 Jun; 62(6):1024-5. PubMed ID: 4712610 [No Abstract] [Full Text] [Related]
9. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Pinder RM; Brogden RN; Speight TM; Avery GS Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989 [TBL] [Abstract][Full Text] [Related]
10. Site of action of dantrolene in frog sartorius muscle. Putney JW; Biancri CP J Pharmacol Exp Ther; 1974 Apr; 189(1):202-12. PubMed ID: 4545054 [No Abstract] [Full Text] [Related]
11. Relationship between serum concentration and daily dose of dantrolene in cerebral palsy patients. Inotsume N; Higashi A; Matsukane I; Chikazawa S; Nakano M; Matsuda I Pediatr Pharmacol (New York); 1986; 5(4):253-9. PubMed ID: 3737270 [TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of dantrolene sodium and its metabolites by differential pulse polarography. Cox PL; Heotis JP; Polin D; Rose GM J Pharm Sci; 1969 Aug; 58(8):987-9. PubMed ID: 5344536 [No Abstract] [Full Text] [Related]
14. In vitro binding of dantrolene to sarcoplasmic reticulum of rabbit skeletal muscle. Dehpour AR; Mofakham S; Mahmoudian M Biochem Pharmacol; 1982 Mar; 31(6):965-8. PubMed ID: 7082378 [TBL] [Abstract][Full Text] [Related]
15. Limitations of fluorescence quenching data analysis in dantrolene binding by human albumin. Kishnani NS; Parsons DL Pharm Acta Helv; 1987; 62(7):178-82. PubMed ID: 3628429 [No Abstract] [Full Text] [Related]
16. Placental transfer of dantrolene. Morison DH Anesthesiology; 1983 Sep; 59(3):265. PubMed ID: 6881602 [No Abstract] [Full Text] [Related]
17. Dantrolene plasma and urine concentrations after oral pretreatment for malignant hyperthermia: report of a case. Wuis EW; Driessen JJ; Evers J; Vree TB; van der Kleyn E Eur J Anaesthesiol; 1986 May; 3(3):219-23. PubMed ID: 3780690 [TBL] [Abstract][Full Text] [Related]
18. [Reduction of dantrolene by enteric bacteria]. Kuroiwa M; Inotsume N; Iwaoku R; Nakano M Yakugaku Zasshi; 1985 Aug; 105(8):770-4. PubMed ID: 4087153 [No Abstract] [Full Text] [Related]
19. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. Free CW; Jaimon MP N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330 [TBL] [Abstract][Full Text] [Related]
20. Dantrolene and suxamethonium. The effect of pre-operative dantrolene on the action of suxamethonium. Collier CB Anaesthesia; 1979 Feb; 34(2):152-8. PubMed ID: 375768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]